PACB vs SOFI · rev $38.4M vs P/E 39, rev $619.4M
Pacific Biosciences of California (PACB) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
PACB currently screens at market cap $387.1M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the PACB and SOFI stock pages for the full models.
Not investment advice.